Special topic of small and medium-sized IPO: secondary new shares: this batch of Tianyue advanced is worthy of key tracking (batch 48 and 49 of 2021)

In this batch, 2 new shares were issued and 12 were registered on the science and innovation board and the gem

The CSRC issued 2 new shares in this batch (2 in the previous batch), and 12 were registered on the science and innovation board and gem (the last batch of 15), the registration speed has decreased. The main board: China Mobile and Huitong group. The science and Innovation Board: xidiwei, Tianyue advanced, Aojie technology, Guoxin technology, Maiwei biology and Weide information. The gem: Tianyi medical, Yidong electronics, adoptive shares, Chengda pharmaceutical, 3D world and Tongguan copper foil. Among them, Tianyue advanced is worthy of key tracking.

Tianyue advanced is the leader of silicon carbide substrate materials in China, and successfully ranks among the first echelon of the industry with leading silicon carbide substrate technology, rich intellectual property accumulation and outstanding industrialization ability. According to the statistics of yole, an international well-known industry consulting organization, from the perspective of sales volume, the market share of the company’s semi insulating silicon carbide substrate ranked third in the world from 2019 to 2020, and the market share increased from 18% to 30% in 2020. The semi insulating silicon carbide substrate is mainly used to manufacture gallium nitride RF devices, and the market prospect is broad. According to yole’s prediction, thanks to the construction of 5g base station and the large demand of radar downstream market, the global market scale of semi insulating silicon carbide substrate for gallium nitride epitaxy has achieved rapid growth. The market shipment of semi insulating silicon carbide substrate will increase from 165600 pieces in 2020 to 438400 pieces in 2025, with a compound growth rate of 21.50%. At the same time, in recent years, a series of industrial policies have been formulated from the state to the local level to promote the development of silicon carbide industry. Downstream application enterprises are also adjusting their supply chain to support Chinese enterprises. The domestic substitution process of silicon carbide industry is expected to be further accelerated. As a leading enterprise of silicon carbide substrate materials in China, the company will fully benefit from the rapid growth of downstream market demand and domestic substitution in the future.

In this period, 15 will be held on the scientific innovation board and gem, and 3 on the main board

In this period, there were 15 meetings on the scientific innovation board and gem, an increase over the previous period of 13, and the passing rate was 73.33%. There were 3 meetings on the main board, the same as the 3 in the previous period, and the passing rate was 66.67%. After excluding financial stocks, the average fund-raising of the scientific innovation board and gem in this period was about 1.334 billion yuan, higher than 944 million yuan in the previous period. The average fund raised by the main board in this period is about 28.101 billion yuan, higher than 1.237 billion yuan in the previous period. In this period, five new shares were listed on the science and innovation board, with an average increase of 58.3% on the first day of listing, higher than 53.1% in the previous period. A total of 11 new shares were listed on the gem in this period, with an average increase of 85.2% on the first day of listing, higher than 81.9% in the previous period. In terms of the increase in the opening of new shares, there were 2 new shares on the main board in the current period, with an average opening increase of 125%, lower than 141% in the previous period.

Key tracking portfolio of open source small and medium cap new shares

Ligao Foods Co.Ltd(300973) (a leading enterprise in frozen and baked food, the industry is in a period of rapid growth and the concentration is still low), Xiangyumedicalco.Ltd(688626) (leading domestic rehabilitation medical devices, which can produce a full range of rehabilitation medical devices, and is expected to continue to benefit from the release of China’s health market demand and the trend of import substitution), Zhejiang Huakang Pharmaceutical Co.Ltd(605077) (xylitol production ranks first in China and second in the world. Functional sugar alcohols are low in calories and do not cause dental caries, and are expected to continuously replace sugar), Marssenger Kitchenware Co.Ltd(300894) (a leading enterprise in high-end integrated stoves, with broad industry penetration space), Pylon Technologies Co.Ltd(688063) (a leading global supplier of energy storage battery system, fully benefiting from the development of renewable energy industry), Shanghai Titan Scientific Co.Ltd(688133) (comprehensive scientific research service provider, rapid expansion of platform), Shanghai Aladdin Biochemical Technology Co.Ltd(688179) (high-end scientific research reagent R & D provider, with broad domestic substitution space).

Risk tips: macroeconomic risks and changes in IPO system.

 

- Advertisment -